|
|
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
Global Biotechnology
4/4/2012 | published by: IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge and biotechnology products and
|
more...
|
$935.00
|
|
Biotechnology in the US - Industry Market Research Report
3/26/2012 | published by: IBISWorld
Biotechnology in the US Wave of the future : Demand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to the recession, healthcare reform, environmental concerns
|
more...
|
$910.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Biologics Market in Brazil
3/2/2012 | published by: Frost & Sullivan
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon,
|
more...
|
$6,000.00
|
|
Antibody Partnering Terms and Agreements
3/1/2012 | published by: Current Partnering
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a
|
more...
|
$2,695.00
|
|
Biosimilars: Current Situation & Future Prospects, Worldwide
3/1/2012 | published by: JustPharmaReports.com
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global
|
more...
|
$3,000.00
|
|
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition
10/15/2011 | published by: Kalorama Information
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the
|
more...
|
$3,500.00
|
